Infasurf Side Effects, Uses, Interactions, Pictures, Warnings & Dosing

- INFASURF
- QTY 3
- 35MG/ML
- VIAL
- Near 77381

CALFACTANT (kal FAKT ant) prevents and treats respiratory distress syndrome (RDS), a condition that can occur in infants whose lungs are not fully developed. It works by helping the air sacs (alveoli) in the lungs stay open, which makes it easier to breathe. It belongs to a group of medications called surfactants.

INFASURF Information

En Español

CALFACTANT (kal FAKT ant) prevents and treats respiratory distress syndrome (RDS), a condition that can occur in infants whose lungs are not fully developed. It works by helping the air sacs (alveoli) in the lungs stay open, which makes it easier to breathe. It belongs to a group of medications called surfactants.

This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
This medication is applied to the lungs through a breathing tube. It is given by your care team in the hospital.
Talk to your care team about the use of this medication in children. While it may be prescribed for children as young as newborn for selected conditions, precautions do apply.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.
NOTE: This medicine is only for you. Do not share this medicine with others.
Side effects that you should report to your care team as soon as possible:
-Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
-Bleeding in the brain—trouble breathing, high-pitched crying, swelling or bulging of soft spots on the head, seizures
-Slow heartbeat or low blood pressure—pale, blue or purple skin or lips, unusual weakness or fatigue, cold arms or legs

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.